Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 1999, p. 7191-7202, Vol. 19, No. 10
Division of Molecular Endocrinology,
Departments of Medicine and Pharmacology,1 and
Structural Biology, Skirball Institute of Biomolecular
Medicine,2 New York University School of
Medicine, New York, New York 10016
Received 25 February 1999/Returned for modification 5 April
1999/Accepted 16 July 1999
Many nuclear receptors are capable of recognizing similar DNA
elements. The molecular event(s) underlying the functional
specificities of these receptors (in regulating the expression of their
native target genes) is a very important issue that remains poorly
understood. Here we report the cloning and analysis of a novel nuclear
receptor coactivator (designated NRIF3) that exhibits a distinct
receptor specificity. Fluorescence microscopy shows that NRIF3
localizes to the cell nucleus. The yeast two-hybrid and/or in vitro
binding assays indicated that NRIF3 specifically interacts with the
thyroid hormone receptor (TR) and retinoid X receptor (RXR) in a
ligand-dependent fashion but does not bind to the retinoic acid
receptor, vitamin D receptor, progesterone receptor, glucocorticoid
receptor, or estrogen receptor. Functional experiments showed that
NRIF3 significantly potentiates TR- and RXR-mediated transactivation in
vivo but has little effect on other examined nuclear receptors. Domain
and mutagenesis analyses indicated that a novel C-terminal domain in
NRIF3 plays an essential role in its specific interaction with liganded
TR and RXR while the N-terminal LXXLL motif plays a minor role in
allowing optimum interaction. Computer modeling and subsequent experimental analysis suggested that the C-terminal domain of NRIF3
directly mediates interaction with liganded receptors through an LXXIL
(a variant of the canonical LXXLL) module while the other part of the
NRIF3 protein may still play a role in conferring its receptor
specificity. Identification of a coactivator with such a unique
receptor specificity may provide new insight into the molecular
mechanism(s) of receptor-mediated transcriptional activation as well as
the functional specificities of nuclear receptors.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
NRIF3 Is a Novel Coactivator Mediating Functional
Specificity of Nuclear Hormone Receptors
*
Corresponding author. Mailing address: Division of
Molecular Endocrinology, Departments of Medicine and Pharmacology, New York University School of Medicine, 550 First Ave., New York, NY 10016. Phone: (212) 263-6279. Fax: (212) 263-7701. E-mail: samueh01{at}mcrcr.med.nyu.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|